Susan Schuh has dedicated her career to helping humans adapt to life beyond Earth. As the Flight Crew Integration Operational ...
Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...
Recent technological advances have set the stage for a renewed focus on human-based solutions called new approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback